Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
AMERISAFE
AMSF
$543M
| $2.56M | ﹤0.01% |
47,954
+21,601
| +82% | +$1.15M |
|
|
VGR
3202
PUT
DELISTED
Vector Group Ltd.
VGR
| $2.55M | ﹤0.01% |
199,300
+147,600
| +285% | +$1.82M |
|
3203
Vicor
VICR
$9.56B
| $2.55M | ﹤0.01% |
47,223
-598,919
| -93% | -$29.6M |
|
3204
Goldman Sachs BDC
GSBD
$969M
| $2.55M | ﹤0.01% |
183,902
+102,047
| +125% | +$1.39M |
|
|
SBXC.U
3205
DELISTED
SilverBox Corp III Units, each consisting of one Class A Common Stock and one-third of one redeemable warrant
SBXC.U
| $2.54M | ﹤0.01% |
250,000
| – | – |
|
3206
BJs Wholesale Club
BJ
$12.5B
| $2.54M | ﹤0.01% |
40,285
-911,753
| -96% | -$63.1M |
|
3207
NextCure
NXTC
$16.8M
| $2.54M | ﹤0.01% |
117,421
-3,747
| -3% | -$73.8K |
|
3208
CALL
Transocean
RIG
$5.89B
| $2.53M | ﹤0.01% |
361,500
+211,500
| +141% | +$1.31M |
|
|
IPXXU
3209
DELISTED
Inflection Point Acquisition Corp. II Unit
IPXXU
| $2.53M | ﹤0.01% |
+250,000
| New | +$2.53M |
|
3210
SkyWater Technology
SKYT
$1.6B
| $2.53M | ﹤0.01% |
268,233
-560,763
| -68% | -$5.39M |
|
|
GRTS
3211
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $2.53M | ﹤0.01% |
1,295,437
+584,219
| +82% | +$1.37M |
|
3212
QuantumScape Corp
QS
$3.21B
| $2.52M | ﹤0.01% |
+315,889
| New | +$2.2M |
|
3213
CenterPoint Energy
CNP
$27.7B
| $2.52M | ﹤0.01% |
86,471
-1,910,165
| -96% | -$56.4M |
|
3214
Atara Biotherapeutics
ATRA
$75.5M
| $2.52M | ﹤0.01% |
62,583
+42,231
| +208% | +$2.39M |
|
3215
CALL
TG Therapeutics
TGTX
$7.96B
| $2.52M | ﹤0.01% |
101,400
-103,000
| -50% | -$2.66M |
|
3216
CALL
American Electric Power
AEP
$69.6B
| $2.52M | ﹤0.01% |
29,900
-17,500
| -37% | -$1.55M |
|
3217
PUT
Viridian Therapeutics
VRDN
$2.09B
| $2.51M | ﹤0.01% |
+105,500
| New | +$2.71M |
|
3218
Stepan Co
SCL
$1.46B
| $2.5M | ﹤0.01% |
26,206
-25,620
| -49% | -$2.43M |
|
3219
PUT
Baxter International
BAX
$13.5B
| $2.5M | ﹤0.01% |
54,900
-100
| -0.2% | -$4.36K |
|
3220
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$154M
| $2.5M | ﹤0.01% |
+25,000
| New | +$3.53M |
|
3221
PUT
Agnico Eagle Mines
AEM
$73.6B
| $2.5M | ﹤0.01% |
50,000
-300
| -0.6% | -$16.2K |
|
3222
Energy Vault
NRGV
$517M
| $2.49M | ﹤0.01% |
913,635
-272,058
| -23% | -$573K |
|
3223
Essex Property Trust
ESS
$18.3B
| $2.49M | ﹤0.01% |
10,644
-126,322
| -92% | -$27.6M |
|
3224
CALL
3M
MMM
$90.9B
| $2.49M | ﹤0.01% |
29,780
-91,614
| -75% | -$7.78M |
|
3225
iShares Core S&P Total US Stock Market ETF
ITOT
$94.3B
| $2.49M | ﹤0.01% |
+25,445
| New | +$2.35M |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.